MOBKL2A inhibitors belong to a chemical class that has attracted attention in scientific research due to their potential involvement in diverse cellular processes. These inhibitors target the MOBKL2A protein, a member of the MOB kinase activator (MOBKL) family, which plays a crucial role in intracellular signaling pathways. MOBKL2A is involved in regulating various cellular functions, including cell cycle progression, cell morphology, and cytoskeletal dynamics. By inhibiting MOBKL2A, these compounds interfere with its normal activity, leading to potential perturbations in intracellular signaling cascades. The precise mechanism of action of MOBKL2A inhibitors is still being elucidated, but it is hypothesized that they disrupt protein-protein interactions or inhibit enzymatic activity. Such interference can have broad-ranging effects on cellular processes that rely on the proper functioning of MOBKL2A. As a result, these inhibitors have garnered interest as valuable tools for investigating fundamental cellular biology and uncovering novel pathways.
Studies exploring the effects of MOBKL2A inhibitors have shown their ability to modulate cellular pathways associated with cell growth, cytoskeletal rearrangements, and cellular responses to external stimuli. By targeting MOBKL2A, these compounds may provide valuable insights into the underlying mechanisms of cellular functions and shed light on the potential dysregulation of MOBKL2A in various physiological and pathological contexts. The chemical properties of MOBKL2A inhibitors may vary based on their specific structures, as they encompass a diverse range of compounds. Researchers employ various strategies to design and synthesize MOBKL2A inhibitors, aiming to optimize their potency, selectivity, and pharmacokinetic properties. This chemical class offers a valuable toolkit for investigating MOBKL2A-mediated signaling pathways, deepening our understanding of cellular biology and providing potential avenues for further scientific exploration. Future studies and rigorous evaluations will be necessary to fully explore their potential implications in the context of human health.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
An alkaloid compound that inhibits a wide range of kinases, including MOBKL2A. | ||||||
CGP 57380 | 522629-08-9 | sc-202993 | 5 mg | $172.00 | 6 | |
A potent inhibitor of the kinase PIM1, which has been reported to inhibit MOBKL2A indirectly by targeting PIM1. | ||||||
GSK 429286 | 864082-47-3 | sc-361200 sc-361200B sc-361200A | 1 mg 5 mg 10 mg | $40.00 $125.00 $235.00 | ||
A selective inhibitor of LATS1 and LATS2 kinases, which are upstream regulators of MOBKL2A signaling pathway. | ||||||
Compound 56 | 171745-13-4 | sc-203430 | 500 µg | $164.00 | 2 | |
A small molecule inhibitor that has been shown to disrupt the interaction between MOBKL2A and its binding partner, MST1. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
Although primarily developed as a Chk1 inhibitor, AZD7762 has also shown inhibitory effects on other kinases, including MOBKL2A. | ||||||
PP 1 | 172889-26-8 | sc-203212 sc-203212A | 1 mg 5 mg | $86.00 $145.00 | 6 | |
A potent and selective inhibitor of multiple kinases, including MOBKL2A. | ||||||
KI 8751 | 228559-41-9 | sc-203090 | 5 mg | $142.00 | 2 | |
An indolinone derivative that has been reported to inhibit multiple kinases, including MOBKL2A. | ||||||
CCT128930 | 885499-61-6 | sc-364459 sc-364459A | 5 mg 10 mg | $156.00 $292.00 | 2 | |
A potent and selective inhibitor of multiple kinases, including MOBKL2A. | ||||||